IGC Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IGC Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q1 2024.
  • IGC Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending March 31, 2024 was $15M, a 10.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $15M +$1.4M +10.3% Mar 31, 2024 10-K 2024-06-24
Q1 2023 $13.6M +$3M +28.4% Mar 31, 2023 10-K 2024-06-24
Q1 2022 $10.6M +$3.49M +49.3% Mar 31, 2022 10-K 2023-07-07
Q1 2021 $7.08M +$1.94M +37.7% Mar 31, 2021 10-K 2022-06-23
Q1 2020 $5.14M +$4.39M +578% Mar 31, 2020 10-K 2021-06-14
Q1 2019 $758K +$181K +31.4% Mar 31, 2019 10-K 2020-07-13
Q1 2018 $577K -$75.3K -11.5% Mar 31, 2018 10-K 2019-06-14
Q1 2017 $652K -$639K -49.5% Mar 31, 2017 10-K 2018-06-21
Q1 2016 $1.29M -$441K -25.4% Mar 31, 2016 10-K 2017-07-14
Q1 2015 $1.73M +$646K +59.5% Mar 31, 2015 10-K 2016-07-14
Q1 2014 $1.09M +$1.98M Mar 31, 2014 10-K 2015-07-14
Q1 2013 -$892K +$1.83M +67.2% Mar 31, 2013 10-K 2013-07-16
Q1 2012 -$2.72M Mar 31, 2012 10-K 2013-07-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.